Development and Validation of the Lupus Impact Tracker: A Patient‐Completed Tool for Clinical Practice to Assess and Monitor the Impact of Systemic Lupus Erythematosus
Open Access
- 22 April 2014
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 66 (10) , 1542-1550
Abstract
Objective: To derive and validate a brief patient‐completed instrument, the Lupus Impact Tracker (LIT), to assess and monitor the impact of systemic lupus erythematosus (SLE).Methods: Items for the LIT were selected from the LupusPRO, a validated patient‐reported outcomes measure, using 3 approaches: confirmatory factor analysis (CFA), stepwise regression, and patient focus groups. CFA was conducted to find items from the LupusPRO that fit a unidimensional structure to allow scoring as a single index. Stepwise regression methods identified items with the strongest relationship (convergent validity) with disease activity measures and patient health rating. Focus groups (n = 26 patients) identified the most important items describing SLE impact. Selected items were evaluated for reliability and validity.Results: CFA found 21 items that fit a unidimensional structure. Stepwise regressions identified 15 of 21 items having good convergent validity with clinical measures. Patient focus groups identified 9 of 15 items as best capturing the impact of SLE. Overall, 7 items were selected across all 3 approaches (CFA, stepwise regression, and focus groups). Another 15 items were selected across 2 approaches. Through consensus with rheumatology clinician experts, a final set of 10 items was selected for the LIT. The LIT items showed good internal consistency (0.89) and test–retest reliabilities (0.87). Mean LIT scores differed significantly (P < 0.05) across criterion groups in the hypothesized direction, providing evidence of discriminant validity and responsiveness.Conclusion: The LIT is reliable and valid in SLE patients and offers a practical way for physicians and patients to assess and monitor the impact of SLE.Keywords
Funding Information
- GlaxoSmithKline (0000)
This publication has 25 references indexed in Scilit:
- Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusArthritis Care & Research, 2007
- Interpretation of Changes in Health-related Quality of LifeMedical Care, 2003
- Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternativesStructural Equation Modeling: A Multidisciplinary Journal, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- SLICC/ACR DAMAGE INDEX IS VALID, AND RENAL AND PULMONARY ORGAN SCORES ARE PREDICTORS OF SEVERE OUTCOME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1996
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1989
- Significance tests and goodness of fit in the analysis of covariance structures.Psychological Bulletin, 1980